Harrington-Smith Kristen 4
4 · ImmunoGen, Inc. · Filed Nov 17, 2021
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Harrington-Smith Kristen
SVP & Chief Commercial Officer
Transactions
- Award
Restricted Stock Unit
2021-11-15+75,000→ 75,000 totalExercise: $0.00From: 2022-11-15→ Common Stock (75,000 underlying) - Award
Common Stock (right to buy)
2021-11-15$5.68/sh+450,000$2,556,000→ 450,000 totalExercise: $5.68From: 2022-11-15Exp: 2032-11-15→ Common Stock (450,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F2]The RSUs vest over a three-year period, with one-third of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.
- [F3]These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant, subject to continued service through each vesting date.